News › Industry News, Patient Care

Singapore Health Sciences Authority Investigating Case of Blindness after Dermal Filler Treatment

September 15, 2023
Syringes

SINGAPORE: The Health Sciences Authority (HSA) is investigating whether there are problems with a batch of dermal fillers after a woman who was administered with it became blind.

The incident, which occurred in July, is the first local adverse event report for blindness resulting from dermal fillers, HSA said in response to queries from CNA on Tuesday (Sep 12).

Dermal fillers are classified by the HSA as Class D medical devices – the highest risk class.

Read more at Channel News Asia >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Acquisition Lets AI and Operators Learn From Nearly $2 Billion in Annual Aesthetics Transactions
    • Galderma Celebrates 30 Years of Restylane
    • FDA Issues Letter to Evolus Over Jeuveau Social Media Promotion
    • North Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • Retatrutide Phase 3 Trial: Adults With Type 2 Diabetes Lost Average of 50 Pounds
Advertisement